Article

Pharmacy Clinical Pearl of the Day: Hepatitis C

Approximately half of people with HCV don't know they're infected, mainly because they have no symptoms.

Clinical Pearl of the Day: Hepatitis C

Hepatitis C virus (HCV) is a viral infection that causes liver inflammation, sometimes leading to serious liver damage.

Insight:

  • HCV spreads through contaminated blood.Approximately half of people with HCV don't know they're infected, mainly because they have no symptoms, which can take decades to appear.
  • The US Preventive Services Task Force recommends that all adults 18 to 79 years of age be screened for HCV, even those without symptoms or known liver disease.
  • Symptoms may include bleeding easily, bruising, fatigue, poor appetite, yellow discoloration, dark-colored urine, itchy skin, fluid build-up, and swelling in the legs.
  • Every chronic HCV infection starts with an acute phase. Acute HCV usually goes undiagnosed because it rarely causes symptoms.
  • Acute HCV infection doesn't always become chronic.
  • Treatment may include medications, surgery, and vaccinations.
  • Medications include Ribavirin, Harvoni, Zepatier, Epclusa, Vosevi, Mavyret, and interferon.

Sources:

Related Videos
Senior Doctor is examining An Asian patient.
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC